Clinical trials for Cancer in United States

A Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors

Study ID: NCT05653882

Sponsor

Asher Biotherapeutics, Inc.

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Study ID: NCT05535166

Sponsor

St. Jude Children's Research Hospital

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Study ID: NCT06480526

Sponsor

St. Jude Children's Research Hospital

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Study ID: NCT04239157

Sponsor

M.D. Anderson Cancer Center

Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients

Study ID: NCT06094257

Sponsor

Weill Medical College of Cornell University

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Study ID: NCT04275557

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®

Study ID: NCT05363826

Sponsor

Photolitec LLC

Pancreatic Cancer Screening for At-risk Individuals

Study ID: NCT05006131

Sponsor

Beth Israel Deaconess Medical Center

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Study ID: NCT06909357

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Psychophysical Studies of Cancer Therapy Pain

Study ID: NCT00515060

Sponsor

M.D. Anderson Cancer Center